Stockscreener 앱 받기
26.11
0.87%
-0.23
시간 외 거래:
26.11
전일 마감가:
$26.34
열려 있는:
$26.5
하루 거래량:
69,261
Relative Volume:
2.06
시가총액:
$300.25M
수익:
$9.71M
순이익/손실:
$-29.96M
주가수익비율:
-7.5029
EPS:
-3.48
순현금흐름:
$-14.79M
1주 성능:
-4.88%
1개월 성능:
+7.83%
6개월 성능:
+0.42%
1년 성능:
+5.97%
1일 변동 폭
$25.53
$26.91
1주일 범위
$24.86
$28.09
52주 변동 폭
$18.35
$35.00
Xoma Royalty Corp Stock (XOMA) Company Profile
명칭
Xoma Royalty Corp
전화
510-204-7239
주소
2200 POWELL STREET, EMERYVILLE, CA
XOMA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
XOMA
Xoma Royalty Corp
|
26.11 | 300.25M | 9.71M | -29.96M | -14.79M | -3.48 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.03 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.74 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
329.77 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
545.11 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
244.32 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Xoma Royalty Corp Stock (XOMA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-17 | 개시 | The Benchmark Company | Buy |
| 2024-04-29 | 개시 | Leerink Partners | Outperform |
| 2021-09-07 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2021-06-29 | 개시 | Aegis Capital | Buy |
| 2021-01-19 | 재확인 | H.C. Wainwright | Buy |
| 2018-01-18 | 재확인 | H.C. Wainwright | Buy |
| 2017-10-17 | 재개 | H.C. Wainwright | Buy |
| 2017-09-05 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2017-06-12 | 개시 | H.C. Wainwright | Buy |
| 2016-11-14 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2016-03-11 | 재확인 | Wedbush | Outperform |
| 2015-07-23 | 다운그레이드 | Jefferies | Buy → Hold |
| 2015-07-22 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2015-07-22 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2014-10-10 | 재개 | ROTH Capital | Buy |
| 2014-04-29 | 업그레이드 | MLV & Co | Hold → Buy |
| 2014-03-11 | 다운그레이드 | MLV & Co | Buy → Hold |
| 2014-03-05 | 재확인 | Ladenburg Thalmann | Buy |
| 2013-10-31 | 재확인 | MLV & Co | Buy |
| 2013-05-09 | 재확인 | Ladenburg Thalmann | Buy |
| 2012-05-14 | 개시 | Cowen & Co | Outperform |
| 2011-03-31 | 재확인 | MLV Capital | Buy |
| 2011-03-23 | 재확인 | RBC Capital Mkts | Outperform |
| 2011-01-06 | 재확인 | Ladenburg Thalmann | Buy |
| 2011-01-04 | 재확인 | Wedbush | Outperform |
모두보기
Xoma Royalty Corp 주식(XOMA)의 최신 뉴스
XOMA Royalty Declares Quarterly Preferred Stock Dividends - GlobeNewswire
XOMA Preferred Stock Pays High-Yield Quarterly Dividend: 8.625% Series A, 8.375% Series B - Stock Titan
Bank of America Corp DE Acquires 2,009 Shares of XOMA Co. (NASDAQ:XOMA) - Defense World
XOMA Co. (NASDAQ:XOMA) Shares Sold by Squarepoint Ops LLC - Defense World
Nuveen Asset Management LLC Increases Stock Position in XOMA Co. (NASDAQ:XOMA) - Defense World
XOMA Co. (NASDAQ:XOMA) Shares Sold by BNP Paribas Financial Markets - Defense World
BioInvent secured up to $30 million from XOMA Royalty - Biostock
Wall Street Zen Upgrades XOMA (NASDAQ:XOMA) to Buy - Defense World
HC Wainwright Issues Positive Outlook for XOMA Earnings - Defense World
XOMA Co. (NASDAQ:XOMAO) Short Interest Update - Defense World
XOMA Co. (NASDAQ:XOMAP) Short Interest Update - Defense World
XOMA’s (XOMA) “Buy” Rating Reaffirmed at HC Wainwright - Defense World
XOMA Royalty purchases mezagitamab royalty rights from BioInvent International for $30M - MSN
XOMA stock holds Buy rating, $104 target from H.C. Wainwright - Investing.com
XOMA stock holds Buy rating, $104 target from H.C. Wainwright By Investing.com - Investing.com South Africa
XOMA Royalty Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) - Benzinga
XOMA Stock: HC Wainwright & Co. Reiterates Buy Rating with $104 - GuruFocus
XOMA Purchases Future Mezagitamab Royalty Interests from BioInve - GuruFocus
XOMA Royalty (XOMA) Acquires Mezagitamab Interests from BioInvent - GuruFocus
XOMA Royalty (XOMA) Acquires Mezagitamab Interests from BioInven - GuruFocus
XOMA Royalty Purchases Mezagitamab Royalty and Milestone - GlobeNewswire
XOMA Royalty Purchases Mezagitamab Royalty and Milestone Rights Held by BioInvent International for up to USD $30 Million - Yahoo Finance
Northern Trust Corp Has $2.40 Million Holdings in XOMA Co. (NASDAQ:XOMA) - Defense World
XOMA (NASDAQ:XOMAO) Stock Price Up 0.1% – Still a Buy? - Defense World
XOMA (NASDAQ:XOMAP) Trading Up 1.5% – Still a Buy? - Defense World
Major Shareholder Sells Massive Chunk of Xoma Stock! - TipRanks
Leerink Partnrs Analysts Boost Earnings Estimates for XOMA - Defense World
FY2026 Earnings Estimate for XOMA Issued By Leerink Partnrs - Defense World
Results: XOMA Royalty Corporation Exceeded Expectations And The Consensus Has Updated Its Estimates - Yahoo Finance
XOMA Royalty First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
XOMA Royalty Reports Strong Q1 2025 Results - TipRanks
XOMA Royalty Corp Q1 2025 Earnings: EPS of $0.24, Revenue Surges to $15.9 Million, Exceeding Estimates - GuruFocus
XOMA (XOMA) Surpasses Q1 Revenue Expectations with Strong Pipeli - GuruFocus
XOMA Royalty (XOMA) Tops Q1 Earnings and Revenue Estimates - Yahoo Finance
XOMA Royalty Corporation Q1 2025 Financial Results - TradingView
XOMA Royalty Corp SEC 10-Q Report - TradingView
XOMA Royalty Reports First Quarter 2025 Financial Results and Highlights Business Achievements - The Manila Times
Wells Fargo & Company MN Grows Stock Holdings in XOMA Co. (NASDAQ:XOMA) - Defense World
Barclays PLC Acquires 1,528 Shares of XOMA Co. (NASDAQ:XOMA) - Defense World
XOMA Royalty to Present at H.C. Wainwright 1st Annual Royalty Company Virtual Conference - GlobeNewswire
XOMA Royalty Corp expected to post a loss of 30 cents a shareEarnings Preview - TradingView
Renaissance Technologies LLC Buys 7,619 Shares of XOMA Co. (NASDAQ:XOMA) - Defense World
JPMorgan Chase & Co. Raises Stake in XOMA Co. (NASDAQ:XOMA) - Defense World
XOMA Co. (NASDAQ:XOMAO) Sees Significant Increase in Short Interest - Defense World
XOMA Co. (NASDAQ:XOMA) Shares Sold by Geode Capital Management LLC - Defense World
Short Interest in XOMA Co. (NASDAQ:XOMAP) Drops By 15.9% - Defense World
Benchmark Begins Coverage on XOMA (NASDAQ:XOMA) - Defense World
Benchmark Initiates Coverage of XOMA Royalty CorporationPreferred Stock (XOMAP) with Buy Recommendation - Nasdaq
Benchmark Initiates Coverage of XOMA Royalty (XOMA) with Buy Recommendation - Nasdaq
XOMA Co. (NASDAQ:XOMAO) Sees Large Decrease in Short Interest - Defense World
Third Harmonic's shutdown, Coherus and Xoma drug sales connectedBizwomen - The Business Journals
Xoma Royalty Corp (XOMA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Xoma Royalty Corp 주식 (XOMA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Hughes Owen | Chief Executive Officer |
May 20 '25 |
Sale |
25.38 |
25,637 |
650,667 |
62,701 |
| BURNS THOMAS M. | SVP, Finance & CFO |
May 19 '25 |
Option Exercise |
0.00 |
17,773 |
0 |
33,045 |
| BURNS THOMAS M. | SVP, Finance & CFO |
May 20 '25 |
Sale |
25.38 |
10,482 |
266,033 |
22,563 |
| BVF PARTNERS L P/IL | 10% Owner |
May 16 '25 |
Sale |
27.10 |
392,723 |
10,642,793 |
1,267,545 |
| Sitko Bradley | Chief Investment Officer |
Apr 07 '25 |
Buy |
24.70 |
2,000 |
49,400 |
5,045 |
| LIMBER JOSEPH M | Director |
Apr 03 '25 |
Buy |
25.24 |
17,935 |
452,631 |
16,524 |
| LIMBER JOSEPH M | Director |
Apr 04 '25 |
Buy |
25.40 |
6,822 |
173,293 |
20,000 |
| LIMBER JOSEPH M | Director |
Apr 07 '25 |
Buy |
25.60 |
5,243 |
134,221 |
10,000 |
| Sitko Bradley | Chief Investment Officer |
Mar 31 '25 |
Buy |
21.04 |
1,245 |
26,201 |
11,484 |
| BURNS THOMAS M. | SVP, Finance & CFO |
Apr 01 '25 |
Buy |
25.46 |
1,000 |
25,460 |
2,000 |
1.45%
0.86%
자본화:
|
볼륨(24시간):